FDA clears Zoll's IBP (invasive blood pressure)/TEMP (temperature) defibrillator:
This article was originally published in Clinica
Zoll Medical has received US FDA 510(k) marketing clearance for its M Series defibrillators with features for invasive blood pressure (IBP) and temperature (TEMP) monitoring. "The addition of IBP and TEMP positions the M Series as the most compact and lightest integrated transport defibrillator," claims Michael Parascandola, a marketing director at the Burlington, Massachusetts firm.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.